# Preventing Postpartum Depression With Intranasal Oxytocin

> **NCT02505984** · PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 56 (actual)

## Conditions studied

- Depression, Postpartum
- Anxiety

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02505984
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2023-05
- **Final completion:** 2023-05
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2025-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02505984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02505984, "Preventing Postpartum Depression With Intranasal Oxytocin". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02505984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*